Articles for author: Russ Cohen

Russ Cohen

Most Popular

Analysis of Positive Retail Data Impact on Direxion Amazon-Focused ETFs Unpacking Implications of Favorable Retail Report on Amazon ETFs

Amazon.com Inc AMZN achieved remarkable success on Thursday. AMZN experienced a boost from strong consumer spending figures, with retail sales surging 1% in July. The positive trend continued on a yearly basis as retail sales jumped by 2.7% compared to a downwardly revised 2% in June. Notably, jobless claims also decreased, contributing to an overall ...

Russ Cohen

Most Popular

Tempus AI Surge Propels Investors: Google and SoftBank Infusions Drive Bullish Run Tempus AI Surge Propels Investors: Google and SoftBank Infusions Drive Bullish Run

Tempus AI Inc. TEM, a cutting-edge healthcare diagnostics company, has been on a tear. The stock established a new high of $47.81 on Thursday. The stock is up 17.27% since its IPO in June. The company, which went public at $37 per share, and has been riding a wave of momentum ever since. Over the ...

Russ Cohen

Most Popular

Market Insights: Did Retail Stocks and Warren Buffett Rescue the Market? Market Insights: Did Retail Stocks and Warren Buffett Rescue the Market?

Yesterday presented a whirlwind of events that could easily give investors a rollercoaster ride. Following the release of economic data earlier in the week and a wave of earnings reports, the market found itself at a crossroads. Warren Buffett, the Oracle of Omaha, made headlines by revealing his latest stock holdings, with Ulta Beauty emerging ...

Russ Cohen

Most Popular

SciSparc Licenses SCI-160 Pain Drug Program to Polyrizon Exploration of SciSparc’s Strategic Move Towards Pain Treatment

Klaus Vedfelt/DigitalVision via Getty Images Amid the ebbs and flows of the stock market, SciSparc (NASDAQ:SPRC) witnessed a staggering 40% surge in post-market trading on a particularly eventful Friday. This surge was the result of the Israeli pharmaceutical company’s strategic decision to exclusively license its SCI-160 pain treatment program to Polyrizon. In a mutually beneficial ...

Russ Cohen

Most Popular

Assessing Berkshire Hathaway’s Response to AI Tailwinds Assessing Berkshire Hathaway’s Response to AI Tailwinds

Berkshire Hathaway, the titan of investing led by the legendary Warren Buffett, appears to be sailing through choppy waters amid the rising tide of artificial intelligence (AI) innovations. The company’s recent move to reduce its exposure to tech giant Apple, a significant player in the AI realm, casts shadows on its readiness to ride the ...